But the importance of CYP-mediated intratumoral degradation of TKI with consequences in terms of treatment efficacy, and resistance is largely unknown whereas tumor-expressed metabolizing enzymes (TEME) can increase cancer cell resistance by significantly lowering intratumoral drug concentration [4]. Here, PPIG is linked to neoplasm.